HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PD 0325901

has antineoplastic activity; appears to be a MEK inhibitor
Also Known As:
PD 325901; PD-0325901; PD-325901; PD0325901; PD325901
Networked: 69 relevant articles (7 outcomes, 12 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ricart, Alejandro D: 3 articles (08/2011 - 03/2010)
2. Cripe, Timothy P: 2 articles (10/2015 - 01/2013)
3. Dombi, Eva: 2 articles (10/2015 - 01/2013)
4. Jousma, Edwin: 2 articles (10/2015 - 01/2013)
5. Ratner, Nancy: 2 articles (10/2015 - 01/2013)
6. Rizvi, Tilat A: 2 articles (10/2015 - 01/2013)
7. Wu, Jianqiang: 2 articles (10/2015 - 01/2013)
8. Kim, Mi-Ok: 2 articles (10/2015 - 01/2013)
9. Cheng, Hui: 2 articles (09/2015 - 01/2015)
10. Chen, Zhong: 2 articles (09/2015 - 01/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
3. Colorectal Neoplasms (Colorectal Cancer)
4. Thyroid Neoplasms (Thyroid Cancer)
5. Stomach Neoplasms (Stomach Cancer)

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. Protein Kinases (Protein Kinase)
3. 2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamide
4. Flutamide (Eulexin)
5. AZD 6244
6. Carbon Monoxide
7. 2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidine
8. Neurofibromin 1 (Neurofibromin)
9. NVP BEZ235
10. Sirolimus (Rapamycin)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Injections
3. Oral Administration